Botulinum toxin for treatment of glandular hypersecretory disorders.

Hdl Handle:
http://hdl.handle.net/10147/208906
Title:
Botulinum toxin for treatment of glandular hypersecretory disorders.
Authors:
Laing, T A; Laing, M E; O'Sullivan, S T
Affiliation:
Department of Plastic and Reconstructive Surgery, Cork University Hospital, Cork,, Ireland.
Citation:
J Plast Reconstr Aesthet Surg. 2008 Sep;61(9):1024-8. Epub 2008 Jul 10.
Journal:
Journal of plastic, reconstructive & aesthetic surgery : JPRAS
Issue Date:
3-Feb-2012
URI:
http://hdl.handle.net/10147/208906
DOI:
10.1016/j.bjps.2008.03.023
PubMed ID:
18619934
Abstract:
SUMMARY: The use of botulinum toxin to treat disorders of the salivary glands is increasing in popularity in recent years. Recent reports of the use of botulinum toxin in glandular hypersecretion suggest overall favourable results with minimal side-effects. However, few randomised clinical trials means that data are limited with respect to candidate suitability, treatment dosages, frequency and duration of treatment. We report a selection of such cases from our own department managed with botulinum toxin and review the current data on use of the toxin to treat salivary gland disorders such as Frey's syndrome, excessive salivation (sialorrhoea), focal and general hyperhidrosis, excessive lacrimation and chronic rhinitis.
Language:
eng
MeSH:
Adolescent; Aged; Aged, 80 and over; Botulinum Toxins, Type A/*therapeutic use; Female; Humans; Hyperhidrosis/drug therapy; Infant; Lacrimal Apparatus Diseases/drug therapy; Male; Middle Aged; Neurotoxins/*therapeutic use; Rhinitis, Vasomotor/drug therapy; Salivary Gland Diseases/*drug therapy; Sialadenitis/drug therapy; Sialorrhea/drug therapy; Sweat Gland Diseases/*drug therapy; Sweating, Gustatory/drug therapy; Treatment Outcome
ISSN:
1878-0539 (Electronic); 1748-6815 (Linking)

Full metadata record

DC FieldValue Language
dc.contributor.authorLaing, T Aen_GB
dc.contributor.authorLaing, M Een_GB
dc.contributor.authorO'Sullivan, S Ten_GB
dc.date.accessioned2012-02-03T15:07:03Z-
dc.date.available2012-02-03T15:07:03Z-
dc.date.issued2012-02-03T15:07:03Z-
dc.identifier.citationJ Plast Reconstr Aesthet Surg. 2008 Sep;61(9):1024-8. Epub 2008 Jul 10.en_GB
dc.identifier.issn1878-0539 (Electronic)en_GB
dc.identifier.issn1748-6815 (Linking)en_GB
dc.identifier.pmid18619934en_GB
dc.identifier.doi10.1016/j.bjps.2008.03.023en_GB
dc.identifier.urihttp://hdl.handle.net/10147/208906-
dc.description.abstractSUMMARY: The use of botulinum toxin to treat disorders of the salivary glands is increasing in popularity in recent years. Recent reports of the use of botulinum toxin in glandular hypersecretion suggest overall favourable results with minimal side-effects. However, few randomised clinical trials means that data are limited with respect to candidate suitability, treatment dosages, frequency and duration of treatment. We report a selection of such cases from our own department managed with botulinum toxin and review the current data on use of the toxin to treat salivary gland disorders such as Frey's syndrome, excessive salivation (sialorrhoea), focal and general hyperhidrosis, excessive lacrimation and chronic rhinitis.en_GB
dc.language.isoengen_GB
dc.subject.meshAdolescenten_GB
dc.subject.meshAgeden_GB
dc.subject.meshAged, 80 and overen_GB
dc.subject.meshBotulinum Toxins, Type A/*therapeutic useen_GB
dc.subject.meshFemaleen_GB
dc.subject.meshHumansen_GB
dc.subject.meshHyperhidrosis/drug therapyen_GB
dc.subject.meshInfanten_GB
dc.subject.meshLacrimal Apparatus Diseases/drug therapyen_GB
dc.subject.meshMaleen_GB
dc.subject.meshMiddle Ageden_GB
dc.subject.meshNeurotoxins/*therapeutic useen_GB
dc.subject.meshRhinitis, Vasomotor/drug therapyen_GB
dc.subject.meshSalivary Gland Diseases/*drug therapyen_GB
dc.subject.meshSialadenitis/drug therapyen_GB
dc.subject.meshSialorrhea/drug therapyen_GB
dc.subject.meshSweat Gland Diseases/*drug therapyen_GB
dc.subject.meshSweating, Gustatory/drug therapyen_GB
dc.subject.meshTreatment Outcomeen_GB
dc.titleBotulinum toxin for treatment of glandular hypersecretory disorders.en_GB
dc.contributor.departmentDepartment of Plastic and Reconstructive Surgery, Cork University Hospital, Cork,, Ireland.en_GB
dc.identifier.journalJournal of plastic, reconstructive & aesthetic surgery : JPRASen_GB
dc.description.provinceMunster-

Related articles on PubMed

All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.